References
- Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo biovailability. Pharm Res 1995;12:413–420
- Butler JM, Dressman JB. The developability classification system: application of biopharmaceutics concepts to formulation development. J Pharm Sci 2010;99:4940–4954
- Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011;420:1–10
- Spence JK, Bhattachar SN, Wesley JA, et al. Increased dissolution rate and bioavailability through comicronization with microcrystalline cellulose. Pharm Dev Technol 2005;10:451–460
- Khan GM, Zhu J-B. Dissolution studies of ibuprofen powders: effect of particle size on dissolution rate and simulation of dissolution process of mixed binary systems. JCPS 1998;7:11–17
- Busson P, Schroeder M. Process for preparing a pharmaceutical composition. US Patent, PCT No WO 2002/00201; 2006
- Sprunk A, Page S, Kleinebudde P. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug. Int J Pharm 2013;455:189–196
- Rauner C. Der Einfluβ verschiedener Carrageenan-Typen auf die Herstellung von Trockenschäumen und der Weiterverarbeitung zu Tabletten [Diploma thesis]. Tübingen: Eberhard-Karls-Universität; 2005
- Wang Y-J, Wang L. Structures and properties of commercial maltodextrins from corn, potato, and rice starches. Starch/Stärke 2000;52:296–304
- Dokic L, Jakovljevic J, Dokic P. Relation between viscous characteristics and dextrose equivalent of maltodextrins. Starch/Stärke 2004;56:520–525
- Preis M, Pein M, Breitkreutz J. Development of a taste-masked orodispersible film containing dimenhydrinate. Pharmaceutics 2012;4:551–562
- Rahman Z, Zidan AS, Khan MA. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation. Int J Pharm 2010;1–2:49–58
- Babbel M, Fritzsching B. Fast dissolving disintegrating tablets with isomalt. Pharm Technol Eur 2009;21:25–28
- Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 2008;25:1663–1676
- Tye CK, Sun CC, Amidon GE. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J Pharm Sci 2005;94:465–472
- Brunauer S, Emmet PH, Teller EJ. Adsorption of gases in multimolecular layers. J Am Chem Soc 1938;60:309–319
- Grain Processing Corporation. Maltrin® – maltodextrins and corn syrup solids [Technical brochure]; 2010. Available from: http://www.grainprocessing.com/pharmaceutical-nutraceutical/technical-bulletins.html [last accessed 4 Apr 2014]
- Fei Y, Kostewicz E, Sheu M-T, Dressman JB. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Eur J Pharm Biopharm 2013;85:1274–1284
- Vogt M, Kunath K, Dressman J. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm 2008;68:283–288